BioCentury
ARTICLE | Clinical News

Prezista darunavir regulatory update

November 19, 2012 8:00 AM UTC

Johnson & Johnson's Janssen Therapeutics division said FDA approved an 800 mg once-daily tablet of HIV drug Prezista darunavir. The company plans to launch the product "shortly." Janssen Therapeutics ...